APAC At-Home Testing Kits Market - Industry Trends and Forecast to 2029

The Asia-Pacific at-home testing kits market is projected to register a substantial CAGR of 6.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
 

Market Segmentation
The Asia-Pacific At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Others), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies), Country (China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, and Rest of Asia-Pacific) Industry Trends and Forecast to 2029
 

Some of the major factors contributing to the growth of the Asia-Pacific at-home testing kits market are:
• Easy availability of self-testing kits at pharmacies
• Increase in awareness about the importance of health diagnosis

Market Players

Some of the major players operating in the Asia-Pacific at-home testing kits market are:

• Abbott, Siemens Healthcare GmbH
• F. Hoffmann-La Roche Ltd
• Drägerwerk AG & Co. KGaA
• Ascensia Diabetes Care Holdings AG
• Nectar Lifesciences Ltd.
• ACON Laboratories
• Quidel Corporation.
• ARKRAY USA
• BTNX INC.
• Atomo Diagnostics
• Eurofins Scientific
• Piramal Enterprises Ltd.
• Bionime Corporation
• Nova Biomedical
• Cardinal Health
• OraSure Technologies
• Everlywell
• SA Scientific Ltd.
• Clearblue